<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03316924</url>
  </required_header>
  <id_info>
    <org_study_id>6834</org_study_id>
    <nct_id>NCT03316924</nct_id>
  </id_info>
  <brief_title>Analysis of in Vitro Biological Reaction of Diaphragmatic Prothesis When Congenital Diaphragmatic Hernia (CDH) Repair</brief_title>
  <official_title>Mecanical Properties of Biomaterials and Biological Integration of Diaphragmatic Prothesis in Infancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In case of CDH, the incomplete development of a part of the diaphragm allows abdominal
      viscera to herniate into thorax cavity during fetal development and impaired lung and heart
      development.

      After birth, CDH patients who survived thanks to an active reanimation management undergo
      diaphragmatic repair. In case of large defect, a patch is needed to complete diaphragmatic
      closure. Thanks to primary cell culture from foreskin, peritoneal epithelium or cremaster
      dedicated to incineration investigators want to analyse biological integration of actually
      used prothesis and others innovations.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 24, 2017</start_date>
  <completion_date type="Anticipated">November 5, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 5, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>cell colonization</measure>
    <time_frame>samples are processed immediately after sampling</time_frame>
    <description>Study cell colonization</description>
  </primary_outcome>
  <primary_outcome>
    <measure>quality of the extracellular matrix</measure>
    <time_frame>samples are processed immediately after sampling</time_frame>
    <description>Quality of the extracellular matrix produced in vitro in contact with the currently used implant materials compared to biomaterials under development</description>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Congenital Diaphragmatic Repair</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Foreskin resection</intervention_name>
    <description>During the pediatric surgery consultation, the doctor will decide between Foreskin resection, orchidopexie or inguinal hernia repair.</description>
    <other_name>orchidopexie</other_name>
    <other_name>inguinal hernia repair</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Children that benefits of a foreskin resection, inguinal hernia repair or orchidopexy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Minor aged 0 (day of birth) to 14 years

          -  Patient for whom an indication of posthectomy and / or cure of inguinal hernia and /
             or testicular ectopy is retained

          -  Patient whose legal representatives have agreed to the use of operational waste from
             mesenchymal tissues (foreskin, cremaster and peritoneum) destined for incineration.

          -  Patient affiliated to a social security scheme

        Exclusion Criteria:

        - parents don't agree to the use of its operating waste for research purposes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Isabelle TALON, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Les Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Isabelle TALON, MD</last_name>
    <phone>+33 3 88 12 72 96</phone>
    <email>isabelle.talon2@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anne SCHNEIDER, MD</last_name>
    <phone>+33 3 88 12 72 93</phone>
    <email>anne.schneider1@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Les Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle TALON, MD</last_name>
      <phone>+33 3 88 12 72 96</phone>
      <email>isabelle.talon2@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Anne SCHNEIDER, MD</last_name>
      <phone>+33 3 88 12 72 93</phone>
      <email>anne.schneider1@chru-strasbourg.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 17, 2017</study_first_submitted>
  <study_first_submitted_qc>October 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 23, 2017</study_first_posted>
  <last_update_submitted>February 23, 2018</last_update_submitted>
  <last_update_submitted_qc>February 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernias, Diaphragmatic, Congenital</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

